Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk

Nakamura, A. et al. High-performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature 554, 249–254 (2018).

CAS 
PubMed 

Google Scholar 

Mattsson, N., Cullen, N. C., Andreasson, U., Zetterberg, H. & Blennow, K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 76, 791–799 (2019).

PubMed 
PubMed Central 

Google Scholar 

Palmqvist, S. et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer’s disease. EMBO Mol. Med. https://doi.org/10.15252/emmm.201911170 (2019).

Kim, K. et al. Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma. Nat. Commun. 11, 119 (2020).

CAS 
PubMed 
…